| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Michael D Capellas is Director at SKIN and has filed Form 4s across 3 companies. Michael D Capellas's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $37.2M at current prices.
Historically, Michael D Capellas's trades have earned a below-average insider score of 25/100 across 4 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -50.3%.
The biggest single holding is FLEX (~$19.3M) as Director. The FLEX filings lean toward selling, a net 78,872 shares.
Michael D Capellas has 44 Form 4 filings on record from August 2016 to December 2025, across 3 companies: Director at Cisco Systems (CSCO), 2018–2025; Director at Beauty Health (SKIN), 2021–2024; Director at Flex (FLEX), 2016–2024.
The 53 reported transactions were 47 stock awards, 3 open-market sales, 2 other transactions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $181K and 2 sales worth about $4.7M.
The only open-market purchase was 30,000 shares of SKIN at an average $6.03 on August 17, 2023, about $181K. Twelve months later SKIN was down 76%.
The largest open-market sale was 78,872 shares of FLEX at an average $33.64 on May 28, 2024, about $2.7M. Twelve months later FLEX was up 25%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.